24 January 2024
Acknowledgment of the Reviewers of BioTech in 2023
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of BioTech. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.
In 2023, BioTech received 212 review reports, from 203 reviewers. This past year, we worked with reviewers from 44 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the BioTech family throughout 2023, and we look forward to their continued support in 2024.
The following are the reviewers who have consented to show their names:
Adel Elamri | Marcello Casertano |
Adelina Dumitras | Marcin Zieliński |
Aditya Velidandi | Marco Mangiagalli |
Adriana Urcan | Maria Di Cicco |
Agustín Herrera-May | Marina Holyavka |
Ahmad Omar | Marino Paroli |
Ajit Singh | Mariusz Hartman |
Andrey Aksenov | Martina Sudar |
Aniruddha Das (Cleveland Clinic Foundation) | Matteo Riccò |
Aniruddha Das (The University of Texas) | Mautusi Mitra |
Arpita Roy | Mengdi Bao |
Artur Słomka | Mpho Mafa |
Barbara Ruffino | Narendar Dudhipala |
Cheng Chang | Norihisa Yasui |
Daniel Costache | Nuno Faria |
Daniel Hernandez-Patlan | Ole Christian Hagestad |
Debasish Dey | Olga Rechkoblit |
Desire Casares Marfil | Paolo Trucillo |
Enrico Maestri | Piotr Latocha |
Enrique Rico-García | Pradeep Panda |
Erick López-Vidaña | Prashant Kaushik |
Ewa Tomaszewska | Qin Xiang Ng |
Francesca Scolari | Qun Tang |
Garry Kerch | Robert Adamu Shey |
Gyula Palyi | Roberta Ibba |
Hailong Qiu | Ronghai Cheng |
Haim Cikurel | S. V. Ramanaiah |
Hao Du | Sai Shilpa Kommaraju |
Hao Wu | Sajed Ali |
Hedvig Fébel | Sajeevan Radha Sivarajan |
Inga Kwiecien | Sajjad Ahmad |
Ioana Ionut | Sami El Khatib |
Jadwiga Wyszkowska | Samir Chtita |
James G. Hecker | Silvia Angelova |
Jan Bocianowski | Stephen Inbaraj |
Jun Wang | Takemichi Fukasawa |
Justyna Miłek | Uelinton Pinto |
Kit-Leong Cheong | Vikram Dalal |
Laura Vicaș | Wen Yang |
Lina Gao | Yu Pi |
Łukasz Szeleszczuk | Yulia Smyatskaya |